Generic vs brand originator alendronate: Analysis of persistence and compliance in five local healthcare units in the lombardy region of Italy

Clinical Cases in Mineral and Bone Metabolism

Volumn 10, Issue 3, 2013, Pages 195-198

  Colombo, Giorgio L ^a   Montecucco, Carlo Maurizio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alendronate; Compliance; Cost analysis; Generic drug; Persistence

Indexed keywords

EID: 84894135448     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pu-noyJ. Impact of European pharmaceutical pnce regulation on generic price coropetition: A review. Pharmacoeconomics 201028(8):649-63.
2. Simoens S. Generic medicine pricing in Europe: Current issues and future perspective. J Med Econ 2008:11(1):171-5. (Pubitemid 351613822)
3. AIFA Italian Medicines Agency-Gruppo di lavoro OSMED. L?uso dei far-maci in Italia, Rapporto OsMed (gennas>settenlbre 2012), December 2012, httpi/www.agenzafamaco.gov.ntentAuso-dei-farmaci-italia-rapporto-osmed-gennaio- settembre-2012 Accessed February 28,2013.
4. Assogenerici, Associazione Nazionale lndustrte Farmaci Generici www.assogenenci.it Accessed February 28, 2013.
5. Peters JR, Hixon OR, Conner OP. Davit RM, Catterson DM, Panse CM. Generic drugs: Safe, effective, and affordable. Dermatol Ther 2009 MayJun22 (3)229-40.
6. Peters JR, Hixon OR, Conner OP, Davit BM, Catterson DM, Panse CM. Generic drugs: Safe, effective, and affordable. Oerrnatol Ther 2009 MayJurt22(3)229-40.
7. Lexciin J. The effect of geneflc cxxrpetition on the price of brand-name drugs. Health Policy 2004 Apr:68(1):47-54.
8. Cerra C, Lottaroli S. Utilizzo di banche dati amministrative peril calcolo del costi di patologie croniche e/o degenerative. Un metodo per a mappatura dei consumi sanitari degli assistiti dat SSN. [Use of administrative databases for calculating the cost of chronic pathologies]. Pharmacoeconomics- Italian Research Articles. 2004:6(3):141-1 Italian.
9. Colornbo GL, Agaba-Rosei E, Margonato A, et al. 0ff-patent generic medicines vs. off-patent brand medicines for six reference drugs. A retrospective claims data study from five Local Healthcare Units i the Lombardy Region of Italy, accepted for publication in PlosOrie, Oecerrter 2013.
10. Osteiberg L Blaschke Adherence to medication. N Engi J Med 2005:453:487-497. (Pubitemid 41127293)
11. Decreto Iegislativo 30 giugno 2003, n. 196, Codice in rnateria di protezione dei dati personali, httpitwww.garariteprivacy.lt/web/guestmome/ docweb//docweb-displayldocweb/131 1248. Accessed November 10, 2013.
12. Ellis JJ, Erickson SR, Stevenson JG, et al. Suboptirnal statw, adherence and discxxitinuation in primary and secondary prevention populations. J Gen Intern Med 2004 Jun:19(6):638-45.
13. Roblin DW, Platt R, Goodman MJ, Hsu J, Nelson WW, Smith OH, Andrade SE, Soumerai SR Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: How much is too much Med Care 2005 Oct.
14. OiMatteo ML, Giordani PJ, Lepper HS, Croghan 7W. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care 2002 40:794-811.